PTPI Archived Articles
Petros Pharmaceuticals (PTPI): Navigating the Path to Prescription-to-OTC Transition for Its Flagship ED Medication
Published on November 30, 2024
Petros Pharmaceuticals, Inc. (NASDAQ:PTPI): Navigating the Evolving ED Landscape with Innovative Strategies
Published on September 24, 2024